| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 15 |
| 1 | TADALAFIL | 13 |
| 2 | AMBRISENTAN | 9 |
| 3 | BISOPROLOL FUMARATE | 9 |
| 4 | TOLVAPTAN | 9 |
| 5 | BOSENTAN | 7 |
| 6 | LEVOTHYROXINE SODIUM | 7 |
| 7 | LEVOTHYROXINE SODIUM ANHYDROUS | 7 |
| 8 | SILDENAFIL | 7 |
| 9 | SILDENAFIL CITRATE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| 1 | NITRIC OXIDE | 3 | 0.0006 |
| 2 | TOLVAPTAN | 9 | 0.0006 |
| 3 | OMEGA-3-ACID ETHYL ESTERS | 1 | 0.0005 |
| 4 | LETERMOVIR | 1 | 0.0003 |
| 5 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| 6 | EDOXABAN TOSYLATE | 2 | 0.0003 |
| 7 | GEMTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 8 | DIPYRIDAMOLE | 1 | 0.0003 |
| 9 | ACARBOSE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin V2 Receptor Antagonist [EPC] | 9 | 0.0006 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 4 | 0.0002 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 16 | 0.0001 |
| 6 | Antimalarial [EPC] | 1 | 0.0001 |
| 7 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 3 | 0.0001 |
| 9 | Barbiturate [EPC] | 1 | 0.0001 |